Articles On Auscann Group Holdings (ASX:AC8)

The Auscann Group Holdings Ltd (ASX: AC8) share price has smoked the All Ordinaries Index (ASX: XAO) today, up 6.2% to 17 cents compared to a 0.3% gain for the All Ords. The Auscann share price movement is in response to an update regardin...

ASX cannabis stocks are continuing their victory lap following yesterday’s decision by the TGA to re-classify low-dose cannabidiol (CBD) products. The TGA has made an interim decision to down schedule CBD products, including oil and pills,...

The market may be sinking lower today but that hasn’t stopped ASX cannabis shares from storming higher. For example, at the time of writing the Althea Group Holdings Ltd (ASX: AGH) share price is up 8% to 54 cents. Elsewhere, the Auscann G...

ASX cannabis shares faded from the spotlight in 2020 as the coronavirus pandemic took over. But the Australian medical marijuana companies have been working through COVID-19 disruptions as they look to scale their businesses. Some have bee...

Nick Woolf (pictured) has been appointed as the new CEO of medicinal cannabis company AusCann (ASX: AC8), bringing considerable experience in the pharmaceuticals space along with him. Woolf's appointment sees him replace former CEO Ido Ka...

Cannabis shares were considered a fad for a while. Now, they’ve proved they’re here to stay. As the Australian medicinal cannabis industry grows, ASX cannabis companies are refining their strategies. While some are focused on cultivation a...

The Althea Group Holdings Ltd (ASX: AGH) share price is on the rise today. This follows an announcement that company’s subsidiary has entered into a cannabis beverage production agreement. Althea’s subsidiary, Peak Processing Solutions, ha...

The S&P/ASX 200 Index (ASX: XJO) has rebounded strongly from yesterday’s selloff. In late morning trade the benchmark index is up 3.05% to 5,893.4 points. Four shares that have failed to follow the market higher today are listed below....

ASX cannabis shares have staged a mixed recovery since March. The Althea Group Holdings Ltd (ASX: AGH) and Cann Group Ltd (ASX: CAN) shares have had strong comebacks but the Auscann Group Holdings Ltd (ASX: AC8) price has been softer. Coro...

S&P Dow Jones Indices has announced the quarterly rebalance of the entire S&P/ASX index hierarchy, revealing which companies have been added and removed. This review of the ASX’s major indices – the S&P/ASX 20, 50, 100, 200, 300...

Since the start of March, six clinical trials involving cannabis treatments around the world have been halted or cancelled altogether due to COVID19 pandemic but 179 are still recruiting, according to the US registry ClinicalTrials.com. Mor...

Queensland medical marijuana group THC Global (ASX:THC) has started selling its products in Australia, with the first one available by prescription under the government’s Special Access Scheme (SAS). THC is one of several companies which an...

ASX cannabis shares have faced a difficult few months. Struck by a capital crunch earlier this year, cannabis shares were then hammered in the March downturn. Last year wasn’t much better, with the vaping crisis and slow roll out of Canada...

The head of one of Australia's leading medicinal cannabis companies AusCann Group Holdings (ASX: AC8) has announced his resignation today, citing personal reasons for the exit. Ido Kanyon joined the Perth-based company a year ago after pr...

ASX cannabis shares are staging a comeback after the depths of the March bear market. Auscann Group Holdings Ltd (ASX: AC8) shares are up over 15% this morning, and 57% from March lows. AusCann has now commenced clinical evaluation of its...

Cancer hopeful Pharmaxis (ASX: PXS) is moving ahead with a treatment for a rare bone cancer called myelofibrosis, after a phase 1b study showed it didn’t have any negative effects on the 16 healthy volunteers who took it. The company is set...

Medicinal cannabis pharmaceutical company AusCann (ASX: AC8) has announced the completion of recruitment and commencement of its first clinical evaluation at an independent clinical site – Nucleus Network.

AusCann Group’s (ASX: AC8) hard shell medicinal cannabis products are now available for prescription Australia-wide, with clinical trials also ready to kick-off into evaluating different doses of its THC-CBD formulations. In parallel with t...

In recent weeks there’s been little to cheer about for holders of cannabis small caps on the ASX. But beyond the bubble of the ASX, some companies may benefit from the crisis. Yesterday Rhys Cohen, principal consultant at FreshLeaf Analytic...

ASX cannabis shares have been hammered in the market downturn as investors turn to safe-haven assets. But while the market has been distracted by the fallout from the coronavirus pandemic, ASX cannabis shares have been quietly expanding th...

The Althea Group Holdings Ltd (ASX: AGH) share price has fallen materially over the last few weeks following the coronavirus-induced market volatility. In fact, it isn’t just Althea which has been impacted. The likes of Auscann Group Holdi...

Reporting season wrapped up last week with the S&P/ASX 200 Index (INDEXASX: XJO) falling more than 10% from recent highs. As fears around the spread of coronavirus escalated, the contagion of fear infected markets, prompting a major c...

Although it is off its lows, the S&P/ASX 200 index is still on course to end the week with a sizeable decline on Friday. In afternoon trade the benchmark index is down 2.55% to 6,487.9 points. Four shares that have fallen more than mos...

The Auscann Group Holdings Ltd (ASX: AC8) share price is crashing lower this morning after the cannabis medicine manufacturer reported a half-year loss. AusCann achieved a number of key milestones during the half as it works to commerciali...

Medicinal cannabis pharmaceutical company AusCann (ASX:AC8) has entered an exclusive distribution agreement with Clifford Hallam Healthcare to store and distribute its products in Australia.

Medicinal cannabis company AusCann Group (ASX: AC8) has announced an exclusive storage and distribution agreement today with national pharmaceuticals provider Clifford Hallam Healthcare (CH2). The move comes within a week of AusCann repor...

The breakdown in the corporate North American marijuana sector is having ramifications in the Australian industry, and it’s unclear how big an impact the ructions will continue to have. Lower than expected take up of recreational marijuana...

The S&P/ASX 200 index has given back its morning gains and is trading notably lower in afternoon trade. At the time of writing the index is down 0.45% to 6,999.5 points. Four shares that are falling more than most today are listed belo...

The AusCann Group Holdings Ltd (ASX: AC8) share price is sinking lower on Thursday following the release of its quarterly update. At the time of writing the medicinal cannabis company’s shares are down 4.5% to 32 cents. At one stage they w...

In afternoon trade the S&P/ASX 200 index is on course to record a strong gain. At the time of writing the benchmark index is up 0.65% to 6,949.5 points. Four shares that are climbing more than most today are listed below. Here’s why th...

The Cann Group Ltd (ASX: CAN) share price was on form again on Monday and recorded another strong gain. The medicinal cannabis company’s shares raced 13% higher to end the day at $1.07. This latest gain means that Cann Group’s shares have...

Althea Group Holdings Ltd (ASX: AGH) shares have jumped as much as 6% higher this morning after a strong operational update from the ASX cannabis company. At the time of writing, Althea shares are trading for 48 cents, up 3.26%. What did...

The Cann Group Ltd (ASX: CAN) share price was the best performer on the All Ordinaries index on Monday before being placed in a trading halt. The cannabis company’s shares were up as much as 28% to $1.03 at one stage today. And were 25.5%...

Last year was a bear market for cannabis stocks globally. During 2019, the excitement that had followed the legalisation of marijuana in many jurisdictions was replaced by cautio as investors realised early forecasts weren’t necessarily ma...

The S&P/ASX 200 index was a strong performer in 2019, ending the year with a return of just over 20% excluding dividends. The benchmark index achieved this despite a number of wobbles along the way. Here are a few ASX lowlights for 201...

The Cann Group Ltd (ASX: CAN) share price has started the week on an incredibly positive note. At the time of writing the cannabis company’s shares are the best performers on the All Ordinaries index. In afternoon trade they are up a massi...

Marijuana is the hottest herb on the planet right now, but while investing in medical cannabis stocks could make you a fortune, it could also risk the house. After a flurry of activity on the ASX in 2017 as the sector kicked off following l...

Cannabis industry is booming at a rapid pace, with several governments creating opportunities for investors by legalising recreational and medicinal cannabis. With increasing legalisation of cannabis, number of investors and entrepreneurs j...

The Elixinol Global Ltd (ASX: EXL) share price looks set to end the week on a very disappointing note. The cannabis company’s shares are down over 9% to a 52-week low of 58 cents this afternoon. This means Elixinol Global’s shares have fal...

Cannabis shares have had a bad run in the second half of 2019. Prices have retreated from the highs seen earlier in the year, led lower by North American cannabis stocks. Could 2020 see a reversal in fortunes? We take a look at 2 ASX cann...

Pot Stocks or Cannabis stocks have gained a lot of popularity in Australia, given that medicinal cannabis was legalised in Australia in February 2016. Various companies have quickly progressed with the various clinical trials of the related...

The AusCann Group Holdings Ltd (ASX: AC8) share price certainly was out of form on Thursday. The medicinal cannabis company’s shares were the worst performers on the All Ordinaries with a decline of 13% to 23.5 cents. Why did the AusCann s...

The S&P/ASX 200 index looks set to finish the day in the red on Thursday. In afternoon trade the benchmark index is 0.15% lower at 6,840.4 points. Four shares that have fallen more than most today are listed below. Here’s why they are...

In morning trade the Cann Group Ltd (ASX: CAN) share price is rocketing higher. At the time of writing the cannabis company’s shares are up 20% to 51 cents. Why is the Cann Group share price rocketing higher? Investors have been buying Can...

Australia’s S&P/ASX 200 (Index: ^AXJO)(ASX: XJO) and ALL ORDINARIES (Index: ^AXAO) (ASX: XAO) indices finished higher on Wednesday. Here’s a short recap of the Australian market: S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) higher 0.06%...

Medicinal cannabis company AusCann Group (AC8) is up more than 65 per cent today after completing manufacturing and testing of its hard-shall capsules Once tested, the capsules were found to have met all applicable criteria set out by the...

AusCann Group Holdings (ASX: AC8) is speeding up plans to bring its proprietary cannabinoid-based hard-shell capsules to market, aiming to make them available for patients in Australia before the first half of next year. The medical cannabi...

After a shaky start, the S&P/ASX 200 index is pushing higher in afternoon trade. At the time of writing the benchmark index is up 0.2% to 6,861.6 points. Four shares that are climbing more than most are listed below. Here’s why they ar...

The best performer on the All Ordinaries index on Wednesday has been the AusCann Group Holdings Ltd (ASX: AC8) share price. In morning trade the cannabis company’s shares were up a whopping 35% to 24.25 cents. They have since pulled back...

There’s no doubt 2019 has been a difficult year for ASX cannabis shares. Many of the ASX-listed producers have struggled to climb higher and, in many cases, have experienced heavy losses. So is there hope for long-term investors in the Aus...